{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:07:27Z","timestamp":1779286047739,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-02773-5","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:15:27Z","timestamp":1779282927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neonatal digital twins enable personalized antibiotic dosing for treating suspected sepsis"],"prefix":"10.1038","volume":"9","author":[{"given":"Margaret Y.","family":"Sui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyra L.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel Yuhan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph C.","family":"Kvedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2773_CR1","doi-asserted-by":"crossref","unstructured":"Wynn, J. L. & Wong, H. R. Pathophysiology of neonatal sepsis. in Fetal and Neonatal Physiol. 1536\u20131552.e10 (Elsevier, 2017).","DOI":"10.1016\/B978-0-323-35214-7.00152-9"},{"key":"2773_CR2","doi-asserted-by":"publisher","first-page":"1180565","DOI":"10.3389\/frmbi.2023.1180565","volume":"2","author":"MM Mulinge","year":"2023","unstructured":"Mulinge, M. M., Mwanza, S. S., Kabahweza, H. M., Wamalwa, D. C. & Nduati, R. W. The impact of neonatal intensive care unit antibiotics on gut bacterial microbiota of preterm infants: a systematic review. Front. Microbiomes 2, 1180565 (2023).","journal-title":"Front. Microbiomes"},{"key":"2773_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/cpt.166","volume":"98","author":"K Allegaert","year":"2015","unstructured":"Allegaert, K. & van den Anker, J. Neonatal drug therapy: the first frontier of therapeutics for children. Clin. Pharm. Ther. 98, 288\u2013297 (2015).","journal-title":"Clin. Pharm. Ther."},{"key":"2773_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01118-24","volume":"69","author":"MAA van der Veer","year":"2025","unstructured":"van der Veer, M. A. A. et al. Amikacin dosing in neonates: evaluation of target attainment using a simplified and complex pharmacokinetic model-derived dosing regimen in clinical practice. Antimicrob. Agents Chemother. 69, e0111824 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2773_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jcph.1315","volume":"59","author":"JC Euteneuer","year":"2019","unstructured":"Euteneuer, J. C., Kamatkar, S., Fukuda, T., Vinks, A. A. & Akinbi, H. T. Suggestions for model-informed precision dosing to optimize neonatal drug therapy. J. Clin. Pharm. 59, 168\u2013176 (2019).","journal-title":"J. Clin. Pharm."},{"key":"2773_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.32607\/20758251-2018-10-4-33-48","volume":"10","author":"AM Egorov","year":"2018","unstructured":"Egorov, A. M., Ulyashova, M. M. & Rubtsova, M. Y. Bacterial enzymes and antibiotic resistance. Acta Nat. 10, 33\u201348 (2018).","journal-title":"Acta Nat."},{"key":"2773_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/eva.12196","volume":"8","author":"AH Melnyk","year":"2015","unstructured":"Melnyk, A. H., Wong, A. & Kassen, R. The fitness costs of antibiotic resistance mutations. Evol. Appl 8, 273\u2013283 (2015).","journal-title":"Evol. Appl"},{"key":"2773_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1128\/AAC.00694-11","volume":"56","author":"AF Mohamed","year":"2012","unstructured":"Mohamed, A. F., Nielsen, E. I., Cars, O. & Friberg, L. E. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob. Agents Chemother. 56, 179\u2013188 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2773_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2025.108919","volume":"270","author":"M Prunella","year":"2025","unstructured":"Prunella, M. et al. Pharmacometric and digital twin modeling for adaptive scheduling of combination therapy in advanced gastric cancer. Comput. Methods Prog. Biomed. 270, 108919 (2025).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"2773_CR10","doi-asserted-by":"publisher","unstructured":"Prunella, M. et al. Evolutionary digital twin framework for optimal aminoglycoside dosing in neonates with suspected sepsis. Npj Digit. Med. https:\/\/doi.org\/10.1038\/s41746-026-02558-w, 1\u201325 (2026).","DOI":"10.1038\/s41746-026-02558-w"},{"key":"2773_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01897-4","volume":"8","author":"JD Iqbal","year":"2025","unstructured":"Iqbal, J. D., Krauthammer, M., Witt, C. M., Biller-Andorno, N. & Christen, M. A consensus statement on the use of digital twins in medicine. Npj Digit. Med. 8, 484 (2025).","journal-title":"Npj Digit. Med."},{"key":"2773_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01073-0","volume":"7","author":"E Katsoulakis","year":"2024","unstructured":"Katsoulakis, E. et al. Digital twins for health: a scoping review. Npj Digit. Med. 7, 77 (2024).","journal-title":"Npj Digit. Med."},{"key":"2773_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01700-24","volume":"10","author":"F Yu","year":"2025","unstructured":"Yu, F., Wang, D., Zhang, H., Wang, Z. & Liu, Y. Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in. mSystems 10, e0170024 (2025).","journal-title":"mSystems"},{"key":"2773_CR14","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1109\/TASE.2025.3605540","volume":"23","author":"C Romano","year":"2026","unstructured":"Romano, C., Domenica Di Benedetto, M. & Borri, A. Evolution-informed modeling and control of tumor growth. IEEE Trans. Autom. Sci. Eng. 23, 3024\u20133037 (2026).","journal-title":"IEEE Trans. Autom. Sci. Eng."},{"key":"2773_CR15","doi-asserted-by":"publisher","first-page":"e0275762","DOI":"10.1371\/journal.pone.0275762","volume":"17","author":"A Ali","year":"2022","unstructured":"Ali, A., Imran, M., Sial, S. & Khan, A. Effective antibiotic dosing in the presence of resistant strains. PLoS ONE 17, e0275762 (2022).","journal-title":"PLoS ONE"},{"key":"2773_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jcph.705","volume":"56","author":"M Wilbaux","year":"2016","unstructured":"Wilbaux, M. et al. Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates. J. Clin. Pharm. 56, 909\u2013935 (2016).","journal-title":"J. Clin. Pharm."},{"key":"2773_CR17","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00467-019-04350-3","volume":"35","author":"HJ Murphy","year":"2020","unstructured":"Murphy, H. J. et al. Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists. Pediatr. Nephrol. 35, 2077\u20132088 (2020).","journal-title":"Pediatr. Nephrol."},{"key":"2773_CR18","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1162\/neco.1997.9.8.1735","volume":"9","author":"S Hochreiter","year":"1997","unstructured":"Hochreiter, S. & Schmidhuber, J. Long short-term memory. Neural Comput. 9, 1735\u20131780 (1997).","journal-title":"Neural Comput."},{"key":"2773_CR19","doi-asserted-by":"publisher","first-page":"e0247403","DOI":"10.1371\/journal.pone.0247403","volume":"16","author":"M van Wincoop","year":"2021","unstructured":"van Wincoop, M., de Bijl-Marcus, K., Lilien, M., van den Hoogen, A. & Groenendaal, F. Effect of therapeutic hypothermia on renal and myocardial function in asphyxiated (near) term neonates: a systematic review and meta-analysis. PLoS ONE 16, e0247403 (2021).","journal-title":"PLoS ONE"},{"key":"2773_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1208\/s12248-023-00851-0","volume":"26","author":"W Krzyzanski","year":"2023","unstructured":"Krzyzanski, W. et al. A population model of time-dependent changes in serum creatinine in (near)term neonates with hypoxic-ischemic encephalopathy during and after therapeutic hypothermia. AAPS J. 26, 4 (2023).","journal-title":"AAPS J."},{"key":"2773_CR21","doi-asserted-by":"publisher","first-page":"610294","DOI":"10.3389\/fphar.2020.610294","volume":"11","author":"T van Donge","year":"2020","unstructured":"van Donge, T., Allegaert, K., Pfister, M., Smits, A. & van den Anker, J. Creatinine trends to detect ibuprofen-related maturational adverse drug events in neonatal life: a simulation study for the ELBW newborn. Front Pharm. 11, 610294 (2020).","journal-title":"Front Pharm."},{"key":"2773_CR22","doi-asserted-by":"crossref","unstructured":"Wildes, D. M. et al. A systematic review of the incidence of acute kidney injury in infants with patent ductus arteriosus. Curr. Pediatr. Rep. 13, 4 (2025).","DOI":"10.1007\/s40124-024-00339-1"},{"key":"2773_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/FTD.0000000000000752","volume":"42","author":"M Li","year":"2020","unstructured":"Li, M. et al. Evaluation of assays to measure aminoglycosides in serum: comparison of accuracy and precision based on external quality assessment. Ther. Drug Monit. 42, 710\u2013715 (2020).","journal-title":"Ther. Drug Monit."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02773-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02773-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02773-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:15:34Z","timestamp":1779282934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02773-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2773"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02773-5","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"389"}}